THE TEAM

PRINCIPLES

Dallas Clouatre, PhD
Dr. Clouatre is a Fellow of the American College of Nutrition and a prominent nutrition consultant and published author.  He is an Associate Editor of TotalHealth magazine and a member of the Editorial Advisory Board of Nutritional Outlook magazine and Recent Patents on Cardiovascular Drug Discovery.

Dr. Clouatre is the author of numerous articles and books. Two recent publications are “Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies” in the Journal of the American College of Nutrition (2015) and “Potential of Diet and Dietary Supplementation to Ameliorate the Chronic Clinical Perturbations of the Metabolic Syndrome” in Nutritional and Integrative Strategies in Cardiovascular Medicine (2015). Other publications include “Grape Seed Extract” in the Encyclopedia Of Dietary Supplements (2nd edition, 2010), “Tocotrienols in Vitamin E: Hype or Science?” and “Vitamin E – Natural vs. Synthetic” in Tocotrienols: Vitamin E Beyond Tocopherols (2009), “Kava Kava: Examining New Reports of Toxicity” in Toxicology Letters (2004) and Anti-Fat Nutrients (4th edition 2004). Dr. Clouatre’s primary research interests are the components of the metabolic syndrome / Syndrome X.  Dr. Clouatre earned his B.A. from Stanford and his Ph.D. from the University of California at Berkeley.

demon1
demon2 Daniel Clouatre, JD, S.B.
Mr. Clouatre has spent over 30 years living and working in Asia where he steeped himself in traditional Chinese, Indian and Indonesian herbal medical systems. While in Asia he spent a significant amount of time in the field and production facilities determining what it takes to find and produce efficacious botanical ingredients and sustainable supply chains. His near native command of Mandarin Chinese, the lingua franca of East Asia, remains an invaluable asset. Mr. Clouatre earned his B.S. from the Massachusetts Institute of Technology and J.D. from the University of Chicago.

SPECIAL RECOGNITION

James Dunn, MD (deceased)
Dr. Dunn was the holder of more than one dozen U.S., Canadian, European and South African patents. The major portion of his patent work covers pharmaceutical delivery technologies. He is the author and/or co-author of 44 published scientific papers. For several years, Dr. Dunn was Assistant Professor of Clinical Pharmacology and of Medicine at the Lousiana State University School of Medicine. He founded VEREX Laboratories in 1981. Dr. Dunn played a seminal role in many of the inventions that underpin Glykon’s (-)-hydroxycitric acid offerings.

demon6